Ethics approval and consent to participate
The study conformed to the guidelines of the Declaration of Helsinki and was approved by the Ethics Committee of The Second Affiliated Hospital of Xuzhou Medical University ([2022] 052501), and this study was registered with the Chinese Clinical Trial Testing Center (ID: ChiCTR2200062400). All participants gave written informed consent.All authors listed meet the authorship criteria according to the latest guidelines of the International Committee of Medical Journal Editors, and that all authors are in agreement with the manuscript. Written informed consent was taken from all the patients. This study was registered in the Chinese Clinical Trial Testing Center (ID: ChiCTR2200062400,04.08.2022)